Zyflo

Active Ingredient(s): Zileuton
FDA Approved: * December 9, 1996
Pharm Company: * CRITICAL
Category: Asthma

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Zyflo Overview

Zileuton (trade name ZYFLO) is an orally active inhibitor of 5-lipoxygenase, and thus inhibits leukotrienes (LTB4, LTC4, LTD4, and LTE4) formation, used for the maintenance treatment of asthma. Zileuton was introduced in 1996 by Abbott Laboratories and is now marketed in two formulations by Cornerstone Therapeutics Inc. under the brand names ZYFLO and ZYFLO CR. The original immediate-release formulation, ZYFLO, is taken four times per day. The extended-release formulation, ZYFLO CR, is taken ...

Read more Zyflo Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Zileuton

Recent Zyflo Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Zyflo: (1 result)

Sorted by National Drug Code

• 10122-901 Zyflo 600 mg Oral Tablet by Cornerstone Therapeutics Inc.

Other drugs which contain Zileuton or a similar ingredient: (2 results)